期刊文献+

左氧氟沙星联合乳酸杆菌阴道胶囊治疗衣原体阳性宫颈炎患者的疗效与安全性 被引量:15

Efficiency and safety of levofloxacin combined with lactobacillus vaginal capsule in treating patients with chlamydia-positive cervicitis
下载PDF
导出
摘要 目的探讨左氧氟沙星联合乳酸杆菌阴道胶囊治疗衣原体阳性宫颈炎患者的疗效与安全性。方法将200例衣原体阳性宫颈炎患者随机分为观察组与对照组。对照组患者采用左氧氟沙星治疗,观察组在对照组基础上使用乳酸杆菌阴道胶囊。比较2组患者临床疗效、衣原体转阴率、阴道清洁程度、复发情况以及不良反应发生率。结果观察组患者治疗总有效率89. 00%,显著高于对照组76. 00%(P <0. 05);观察组患者转阴率显著高于对照组(P <0. 05)。治疗后,2组患者阴道清洁度评分均显著降低,且观察组患者阴道清洁度评分显著高于对照组(P <0. 05)。2组患者不良反应发生率与复发率比较,差异无统计学意义(P> 0. 05)。结论左氧氟沙星联合乳酸杆菌阴道胶囊治疗衣原体阳性宫颈炎患者安全有效。 Objective To explore the safety and efficiency of levofloxacin combined with lactobacillus vaginal capsules in treating patients with chlamydia-positive cervicitis.Methods A total of200patients with chlamydia-positive cervicitis were randomly divided into observation group and control group.The control group was treated with levofloxacin,while the observation group was treated with lactobacillus vaginal capsule on the basis of the control group.The clinical efficiency,negative conversion rate of chlamydia,vaginal cleanliness,recurrence condition and incidence rate of adverse reactions were compared between two groups.Results The total effective rate of the observation group was89.00%,which was significantly higher than76.00%of the control group(P<0.05).The negative conversion rate of the observation group was significantly higher than that of the control group(P<0.05).After treatment,the vaginal cleanliness scores in both groups significantly reduced,and the vaginal cleanliness score of the observation group was significantly higher than that of the control group(P<0.05).There were no significant differences in the incidence rate of adverse reactions and recurrence rate between the two groups(P>0.05).Conclusion Levofloxacin combined with lactobacillus vaginal capsule is effective and safe in treating patients with chlamydia-positive cervicitis.
作者 张芳 陈远兰 杨丽珍 ZHANG Fang;CHEN Yuanlan;YANG Lizhen(Department of Gynecology and Obstetrics, Jingjing Hospital of Jingbian County, Yulin, Shaanxi, 718500;Department of Gynecology and Obstetrics, Pingli County Hospital, Pingli, Shaanxi, 725500;Department of Gynecology and Obstetrics, Xianyang Rainbow Hospital, Xianyang, Shaanxi, 712000)
出处 《实用临床医药杂志》 CAS 2018年第23期144-146,共3页 Journal of Clinical Medicine in Practice
基金 陕西省科技计划项目(2016KRM075)
关键词 左氧氟沙星 乳酸杆菌阴道胶囊 衣原体 宫颈炎 转阴率 levofloxacin lactobacillus vaginal capsule chlamydia cervicitis negative conversion rate
  • 相关文献

参考文献15

二级参考文献93

  • 1郑晶晶,宋静慧.乳酸杆菌及阴道微生态制剂[J].内蒙古医科大学学报,2008,30(S2):141-144. 被引量:6
  • 2廖红,董志,傅洁民.甲壳素及其衍生物在烧伤、烫伤方面的作用及应用[J].西部药学,2004,1(1):32-33. 被引量:7
  • 3丰有吉.妇产科学[M].第2版.北京:人民卫生出版社,2010:68-69.
  • 4Thorsten V, Ralf O, Brigitte P. Ureaplasma urealyticum-harm- less commensal or underestimated enemy of human repmducfion [ J]. Arch Gynecol Obstet ,2005,273 ( 3 ) : 133 - 139.
  • 5Kayoko Haradal, Hiroyuki Tanakal, Shinji komoril, et al. Shinji KomorilVaginal infection with Ureaplasma urealyticum accounts for preterm delivery via induction of inflammatory responses[ J]. Microbiol Immuno1,2008 ,52 :297 - 304.76.
  • 6Wasiela M, Brzezinska - Blaszczyk E, Krzeminski Z, et al. Im- pact of Mycoplasma hominis and Ureaplasma urealyticum on the concentration of proinflammatory cytokines in vaginal fluid [ J ]. Med Dosw Mikrobiol, 2004,56 (4) : 371 - 376.
  • 7Wasiela M, Brzezifiska - Blaszczyk E, Krzemi,Sski Z, et al. Im- pact of Mycoplasma hominis and Ureaplasma urealyticum on the concentration of proinflammatory cytokines in vaginal fluid [ J ]. Med Dosw Mikrobio1,2004,56 (4) :371 - 3.
  • 8谢幸.妇产科学[M].北京:人民卫生出版社,2013:274.
  • 9李润铭,邓顺周.甲壳素及壳聚糖在医药领域的应用研究进展[J].食品与药品,2007,9(12A):50-53. 被引量:17
  • 10Ujevi e B, Habek JC, Habek D. Prevalence of infection with Neisseria gonorrhoeae or Chlamydia t,achomatis in acute muco- purulent cervicitis [ J ] . Arh Hig Rada Toksikol, 2009, 60 (2) : 197 -203.

共引文献312

同被引文献130

引证文献15

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部